Table 2 Relationship between quantitative hemostatic/inflammatory parameters and the clinical spectrum of covid-19.
From: Correlating COVID-19 severity with biomarker profiles and patient prognosis
Biomarker | Groups | P-value |
|---|---|---|
Fibrinogen (mg/dL) | Mild | 1 |
Moderate | > 0.99 | |
Severe | 0.39 | |
Factor VIII (%) | Mild | 1 |
Moderate | 0.49 | |
Severe | 0.046* | |
Von Willebrand Factor (%) | Mild | 1 |
Moderate | 0.76 | |
Severe | 0.035* | |
Dimer D (µg/L) | Mild | 1 |
Moderate | 0.42 | |
Severe | 0.002 ** | |
IL-6 (pg/mL) | Mild | 1 |
Moderate | 0.95 | |
Severe | > 0.99 | |
TNF-ɑ (pg/mL) | Mild | 1 |
Moderate | 0.98 | |
Severe | 0.68 | |
Platelet (plaq/mm3) | Mild | 1 |
Moderate | 0.67 | |
Severe | > 0.99 | |
Anticardiolipin IgG (GPL-U/ml) | Mild | 1 |
Moderate | 0.06 | |
Severe | 0.53 | |
Anticardiolipin IgM (MPL-U/ml) | Mild | 1 |
Moderate | 0.818 | |
Severe | > 0.99 | |
Anti-B2 glycoprotein I IgG (GPL-U/ml) | Mild | 1 |
Moderate | > 0.99 | |
Severe | 0.25 | |
Anti-B2 glycoprotein I IgM (GPL-U/ml) | Mild | 1 |
Moderate | 0.56 | |
Severe | > 0.99 | |
Lupus anticoagulant (absence/ presence) | Mild | 0.05 |
Moderate | ||
Severe | ||
Free S protein (%) | Mild | 1 |
Moderate | 0.14 | |
Severe | 0.011* | |
Thrombin time (TT) | Mild | 1 |
Moderate | 0.86 | |
Severe | < 0.001*** | |
Activated partial thromboplastin time (R) | Mild | 1 |
Moderate | > 0.99 | |
Severe | > 0.99 | |
Prothrombin time (INR) | Mild | 1 |
Moderate | 0.006** | |
Severe | 0.008** | |
Glycated hemoglobin (%) | Mild | 1 |
Moderate | 0.25 | |
Severe | < 0.001*** |
